Pyridine derivatives as cb2 receptor modulators
CA 2500231 A1 · Owner: Eatherton, Andrew John · Inventors: Eatherton, Andrew John; Slingsby, Brian Peter; Naylor, Alan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to novel pyridine derivatives pharmaceutical , compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 25, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 25, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 25, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.